Valuation: Sunflower Pharmaceutical Group Co.,Ltd

Market Cap 7.25B 1.07B 935M 861M 799M 1.52B 102B 1.54B 10.31B 4.01B 49.98B 4.01B 3.92B 173B P/E 2024
24.4x
P/E 2025 -33.6x
Enterprise Value 4.76B 701M 614M 565M 525M 996M 66.84B 1.01B 6.77B 2.63B 32.81B 2.63B 2.57B 114B EV / Sales 2024
2.87x
EV / Sales 2025 2.65x
Free-Float
42.64%
Yield 2024
2.44%
Yield 2025 1.35%
1 day+1.76%
1 week+8.05%
Current month+13.74%
1 month-0.16%
3 months+2.82%
6 months-14.77%
Current year-13.68%
1 week 11.04
Extreme 11.04
12.95
1 month 11.04
Extreme 11.04
12.95
Current year 11.04
Extreme 11.04
15.19
1 year 11.04
Extreme 11.04
17.17
3 years 11.04
Extreme 11.04
30.79
5 years 11.04
Extreme 11.04
31.48
10 years 11.04
Extreme 11.04
31.48
Manager TitleAgeSince
Chief Executive Officer 44 2019-01-06
Director of Finance/CFO 49 2021-12-05
Human Resources Officer 48 -
Director TitleAgeSince
Director/Board Member 66 2014-03-25
Director/Board Member 64 2017-09-25
Director/Board Member 44 2017-09-25
Date Insider Type Main position Quantity % Market Cap.
24-07-16Buy 500 0.0001%
20-01-21Sell

Director

246,300 0.0462%
19-12-31Sell 21,300 0.0040%
Change 5-day change 1-year change 3-year change Capi.($)
+1.76%+8.05%-19.30%-44.66% 1.1B
+0.86%+1.55%-11.67%-4.90% 12.94B
+1.50%+0.68%-33.62%-55.63% 4.79B
+0.96%+3.80%-7.08%-2.70% 4.49B
+0.30%+5.58%+23.58%-1.26% 3.92B
+1.15%+1.67%+5.33%-37.13% 3.89B
+3.07%+5.48%-9.42%+6.42% 3.17B
+3.78%-11.63%-10.45%-14.58% 3.16B
+1.63%+2.24%-6.44%-22.75% 2.41B
+2.80%+7.03%-9.40%+39.83% 1.77B
Average +1.78%+6.88%-7.85%-13.74% 4.16B
Weighted average by Cap. +1.46%+5.53%-8.33%-13.22%

Financials

2024 2025
Net sales 3.38B 497M 435M 401M 372M 707M 47.41B 716M 4.8B 1.87B 23.27B 1.87B 1.83B 80.69B 2.32B 341M 299M 275M 255M 485M 32.54B 492M 3.29B 1.28B 15.97B 1.28B 1.25B 55.38B
Net income 492M 72.42M 63.42M 58.42M 54.22M 103M 6.91B 104M 699M 272M 3.39B 272M 266M 11.76B -258M -37.95M -33.23M -30.61M -28.41M -53.96M -3.62B -54.69M -366M -143M -1.78B -143M -139M -6.16B
Net Debt -2.29B -337M -295M -272M -252M -479M -32.14B -486M -3.25B -1.27B -15.78B -1.27B -1.24B -54.7B -2.49B -367M -321M -296M -275M -522M -34.99B -529M -3.54B -1.38B -17.17B -1.38B -1.35B -59.55B
Logo Sunflower Pharmaceutical Group Co.,Ltd
Sunflower Pharmaceutical Group Co Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs, chemical drugs, biopharmaceuticals and health products. The Company operates its businesses through three segments. The Headquarters Segment is responsible for investment management. The Pharmaceutical segment is mainly responsible for pharmaceutical production and sales. Other segment is mainly responsible for the production of packaging materials and the cultivation and research of Chinese herbal medicines. The Company’s main products include Weikangling capsules, liver tablets, hyperactivity cough oral liquid for children use, pediatric Huatanzhike particles, Kangfu anti-inflammatory suppository and pediatric paracetamol particles, among others. The Company distributes its products in the domestic market.
Employees
5,025
Date Price Change Volume
26-07-06 CN¥12.75 +1.76% 8,482,400
26-07-03 CN¥12.53 +3.55% 7,315,100
26-07-02 CN¥12.10 +2.11% 7,190,839
26-07-01 CN¥11.85 +5.71% 6,847,218
26-06-30 CN¥11.21 -5.00% 5,895,300

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002737 Stock